FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 154 filers reported holding FIBROGEN INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $99,576 | -90.7% | 36,880 | -35.4% | 0.00% | -100.0% |
| Q1 2023 | $1,065,075 | -13.1% | 57,078 | -26.2% | 0.00% | 0.0% |
| Q4 2022 | $1,225,022 | +166.1% | 77,307 | +118.5% | 0.00% | – |
| Q3 2022 | $460,281 | +20.4% | 35,379 | -2.3% | 0.00% | – |
| Q2 2022 | $382,346 | -12.7% | 36,207 | -0.6% | 0.00% | – |
| Q1 2022 | $437,853 | -30.8% | 36,427 | -18.8% | 0.00% | – |
| Q4 2021 | $633,000 | +34.7% | 44,872 | -2.3% | 0.00% | – |
| Q3 2021 | $470,000 | -63.8% | 45,941 | -5.8% | 0.00% | -100.0% |
| Q2 2021 | $1,299,000 | -21.4% | 48,761 | +2.4% | 0.00% | 0.0% |
| Q1 2021 | $1,652,000 | -11.8% | 47,598 | -5.7% | 0.00% | -50.0% |
| Q4 2020 | $1,873,000 | -6.4% | 50,494 | +3.7% | 0.00% | 0.0% |
| Q3 2020 | $2,002,000 | -0.3% | 48,685 | -1.6% | 0.00% | 0.0% |
| Q2 2020 | $2,008,000 | +15.7% | 49,466 | -1.0% | 0.00% | 0.0% |
| Q1 2020 | $1,736,000 | -13.3% | 49,965 | +7.0% | 0.00% | 0.0% |
| Q4 2019 | $2,003,000 | +10.1% | 46,695 | -3.0% | 0.00% | 0.0% |
| Q3 2019 | $1,819,000 | -16.9% | 48,115 | -0.7% | 0.00% | -33.3% |
| Q2 2019 | $2,189,000 | -19.1% | 48,456 | -2.6% | 0.00% | 0.0% |
| Q1 2019 | $2,705,000 | +13.5% | 49,772 | -3.4% | 0.00% | 0.0% |
| Q4 2018 | $2,384,000 | -19.2% | 51,516 | +6.0% | 0.00% | 0.0% |
| Q3 2018 | $2,951,000 | -14.9% | 48,580 | -12.3% | 0.00% | -25.0% |
| Q2 2018 | $3,468,000 | +44.3% | 55,392 | +6.5% | 0.00% | +33.3% |
| Q1 2018 | $2,404,000 | -4.6% | 52,031 | -2.2% | 0.00% | 0.0% |
| Q4 2017 | $2,521,000 | -6.9% | 53,197 | +5.7% | 0.00% | 0.0% |
| Q3 2017 | $2,708,000 | +81.1% | 50,325 | +8.7% | 0.00% | +50.0% |
| Q2 2017 | $1,495,000 | +47.0% | 46,284 | +12.2% | 0.00% | +100.0% |
| Q1 2017 | $1,017,000 | +30.6% | 41,262 | +13.3% | 0.00% | 0.0% |
| Q4 2016 | $779,000 | +3.5% | 36,419 | +0.1% | 0.00% | 0.0% |
| Q3 2016 | $753,000 | +26.3% | 36,391 | +0.2% | 0.00% | 0.0% |
| Q2 2016 | $596,000 | -10.6% | 36,320 | +12.2% | 0.00% | 0.0% |
| Q1 2016 | $667,000 | -31.2% | 32,370 | +1.7% | 0.00% | 0.0% |
| Q4 2015 | $970,000 | +40.4% | 31,843 | +1.0% | 0.00% | 0.0% |
| Q3 2015 | $691,000 | -4.7% | 31,526 | +2.2% | 0.00% | 0.0% |
| Q2 2015 | $725,000 | +283.6% | 30,858 | +412.3% | 0.00% | – |
| Q1 2015 | $189,000 | +204.8% | 6,024 | +166.7% | 0.00% | – |
| Q4 2014 | $62,000 | – | 2,259 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 605,713 | $9,703,522 | 5.73% |
| ARMISTICE CAPITAL, LLC | 3,864,000 | $61,901,280 | 1.08% |
| Logos Global Management LP | 525,000 | $8,410,500 | 0.98% |
| 5AM Venture Management, LLC | 225,583 | $3,613,840 | 0.97% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $3,064,626 | 0.91% |
| BHK Investment Advisors, LLC | 87,550 | $1,402,551 | 0.79% |
| Integral Health Asset Management, LLC | 175,000 | $2,803,500 | 0.59% |
| Nan Fung Group Holdings Ltd | 34,106 | $546,378 | 0.38% |
| Soleus Capital Management, L.P. | 113,463 | $1,817,677 | 0.26% |
| Point72 Asset Management, L.P. | 4,781,645 | $76,601,953 | 0.26% |